Why and how should we measure the long-term consequences of rectal cancer treatment?

Current Colorectal Cancer Reports

Volumn 7, Issue 1, 2011, Pages 97-104

  Spindler, Karen Lise Garm ^a   Sebag Montefiore, David ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Late toxicity; Quality of life; Radiotherapy; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHRONIC TOXICITY; EJACULATION DISORDER; HUMAN; INTESTINE OBSTRUCTION; LONG TERM CARE; NAUSEA; NEUROGENIC BOWEL; OVERALL SURVIVAL; PATIENT ASSESSMENT; PREOPERATIVE COMPLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RECTUM SURGERY; REVIEW; SEXUAL DYSFUNCTION; TOXICITY;

EID: 79952695818     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-010-0077-7     Document Type: Review

References (33)

1. Gérard JP, Azria D, Gourgou-Bourgade S, et al. :Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol. 2010, 28:1638-44.
2. Gollins SW, Myint S, Susnerwala S, et al.: Preoperative down-staging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2).Br J Cancer. 2009,101:924-34.
3. Glynne-Jones R, Dunst J, Sebag-Montefiore D, et al.: The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? Ann Oncol. 2006, 17:361-71. Review.
4. Wadlow RC, Ryan DP: The role of targeted agents in preoperative chemoradiation for rectal cancer. Cancer 2010 Apr 29. [Epub ahead of print].
5. Arbea L, Ramos LI, Martínez-Monge R, et al.: Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol, 2010, 5:17.
6. Sun Myint A, Lee CD, Snee AJ, et al.: High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience. Clin Oncol (R Coll Radiol). 2007, 9:711-9. (Pubitemid 47471505)
7. Jakobsen A, Mortensen JP, Bisgaard C, et al.: Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.Int J Radiat Oncol Biol Phys. 2006, 64:461-5.
8. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997, 336:980-7.
9. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001, 345:638-46.
10. Sebag-Montefiore D, Stephens RJ, Steele R, et al.: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009, 373:811-20
11. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al.: Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006, 93:1215-23. (Pubitemid 44547018)
12. Ngan S, Fisher R, Goldstein D, et al.: A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS). J Clin Oncol 28:15s, 2010 (suppl; abstr 3509)
13. Gérard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006, 24:4620-5. (Pubitemid 46630960)
14. Bosset JF, Collette L, Calais G, et al.: EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer.N Engl J Med. 2006, 355:1114-23. Erratum in: N Engl J Med. 2007, 357:728.
15. Sauer R, Becker H, Hohenberger W, et al.: German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004, 351:1731-40.
16. Dahlberg M, Glimelius B, Graf W, et al.: Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum. 1998, 415:543-9.
17. Birgisson H, Påhlman L, Gunnarsson U, et al. Swedish Rectal Cancer Trial Group. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol. 2005, 23:8697-705. (Pubitemid 46211513)
18. Graf W, Ekström K, Glimelius B, et al.: A pilot study of factors influencing bowel function after colorectal anastomosis.Dis Colon Rectum. 1996, 39:744-9
19. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990, 62:1034-8.
20. Marijnen CA, van de Velde CJ, Putter H, et al.: Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005 Mar 20;23(9):1847-58. (Pubitemid 46211362)
21. Peeters KC, van de Velde CJ, Leer JW, et al.: Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - a Dutch colorectal cancer group study. J Clin Oncol. 2005, 23:6199-206.
22. Ware JE, Jr., Sherbourne CD.: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30:473-83.
23. Sprangers MA, te Velde A, Aaronson NK.: The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer. 1999, 35:238-47. (Pubitemid 29136774)
24. Stephens RJ, Thompson LC, Quirke P, et al. Impact of Short-Course Preoperative Radiotherapy for Rectal Cancer on Patients' Quality of Life: Data From the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 Randomized Clinical Trial. J Clin Oncol. 2010 Jun 28. [Epub ahead of print]. This article presents the largest dataset from a randomized trial with key information on bowel and male sexual function.
25. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1341-6.
26. LENT SOMA tables. Radiother Oncol. 1995, 35:17-60.
27. Pietrzak L, Bujko K, Nowacki MP, et al.:.Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial.Radiother Oncol. 2007, 84:217-25.
28. Aaronson NK, Ahmedzai S, Bergman B, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85:365-76. (Pubitemid 23073154)
29. McLachlan S, Fisher R, McClure B, et al.: A comparison of quality of life in patients with T3 rectal cancer receiving short course versus long course preoperative radiation. A Trans-Tasman Radiation Oncology Group Trial (TROG 01.04) Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008: 4097 This study reports recent data of quality of life from a prospective evaluation in a randomized trial.
30. WHO toxicity criteria, no version cited.
31. Seegenschmiedt MH, Sauer R. The systematics of acute and chronic radiation sequelae. Strahlenther Onkol. 1993, 169:83-95. (Pubitemid 23116642)
32. Slee VN.: The International Classification of Diseases: ninth revision (ICD-9). Ann Intern Med. 1978, 88:424-6.
33. Pieterse AH, Stiggelbout AM, Baas-Thijssen MC, et al.: Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences. Br J Cancer. 2007, 97:717-24. This article raises important questions of patients' and clinicians' preferences. It underlines the importance of a search for reliable tools to aid in comprehensive information and involvement of the patients in the decision-making process.